cell

(redirected from squamous cell)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.

cell

(Enemy combatants), noun enemy group, exxremist group, rebel organization, saboteurs, subversives, unnerground extremists
Associated concepts: enemy combatants, justice courts, miliiary tribunals, Patriotic Act, prison cells, sleeper cell, terrorist cell

cell

(jail), noun cage, cella, chamber, compartment, confined room, confinement, cubicle, cubiculum, enclosed cage, incarceration, jailhouse, penitentiary, pound, prison, prison house, small cavity, small room, solitary abode
See also: chamber, jail, penitentiary, prison

CELL. A small room in a prison. See Dungeon.

References in periodicals archive ?
Overall, the most common malignancy was squamous cell carcinoma (79.
64 for patients diagnosed as Well Differentiated Squamous Cell Carcinoma (SCC-WD), 63.
The authors added that more high-quality studies were needed and that studies should evaluate the risk of squamous cell and basal cell cancer separately, because of the apparent difference in risk.
Prognosis for oral squamous cell carcinoma depends on the tumor's size and location, and whether the cancer has spread.
Various treatment modalities have been attempted for squamous cell carcinoma in birds, including surgical excision, (4,6,14,16) photodynamic therapy, (10,15) intralesional cisplatin.
CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early-and late-stage oral squamous cell carcinoma-A pilot study.
A review of the Recurrent Head And Neck Cancer Squamous Cell Carcinoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Throughout the study period the prevalence of Squamous Cell Carcinoma was increased from 17.
Methods: Seventy-six cervical squamous cell carcinoma patients enrolled in our hospital from October 2011 to April 2013 were selected, and another 76 healthy females (without cervical tissue lesions) were enrolled as the control.
The phase 3 clinical trial was a multicenter, randomized, double-blind, placebo-controlled study investigating nimotuzumab for first-line therapy in patients with unresectable and locally advanced squamous cell lung cancer.

Full browser ?